Engerix-b 20 MCG/ML syrnml
Ended Awarded
- Contract number
- SPE2DB25FR3FM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,220
Award facts
- Contract value 100% obligated
- $18,219.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,219.82 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 mcg/mL syringes, a hepatitis B vaccine product. This firm fixed-price, competitively awarded contract reflects no set-aside designation and is scheduled for ultimate completion by August 25, 2025. The award was issued on August 22, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order, this contract draws from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor that supplies an extensive portfolio of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability to fulfill open competition procurements for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for hepatitis B vaccine syringes supports the military's immunization requirements and aligns with the company's established role as a primary pharmaceutical vendor within the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FR3FM?
SPE2DB25FR3FM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FR3FM worth?
The government has obligated $18,220 on SPE2DB25FR3FM.
Is contract SPE2DB25FR3FM an order under another contract?
Yes. SPE2DB25FR3FM is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB25FR3FM competed?
The extent of competition for SPE2DB25FR3FM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award